Multinational healthcare company Johnson & Johnson (NYSE:JNJ) in Q4 CY2024, with sales up 5.3% year on year to $22.52 billion. Its non-GAAP profit of $2.04 per share was 1.3% above analysts’ consensus ...
Hosted on MSN55m
Neogen (NASDAQ:NEOG) Posts Better-Than-Expected Sales In Q4Life sciences company Neogen (NASDAQ:NEOG) in Q4 CY2024, but sales were flat year on year at $231.3 million. Its non-GAAP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback